澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

MAYNE PHARMA GROUP LTD

2.610

-0.040-1.51%

成交量：129.68万

成交额：338.85万

市值：2.12亿

市盈率：-2.20

高：2.660

开：2.640

低：2.600

收：2.650

52周最高：7.310

52周最低：2.600

股本：8,124.58万

流通股本：6,699.72万

量比：4.67

换手率：1.94%

股息：- -

股息率：- -

每股收益(TTM):-1.188

每股收益(LYR):-1.186

净资产收益率：-21.85%

总资产收益率：-1.28%

市净率：0.57

市盈率(LYR):-2.20

数据加载中...

总览公司新闻资讯公告

概念

医药生物股-3.68%

资金流向

资金流入：

资金流出：

新闻资讯

Mayne制药集团——将继续推进产品组合规模化战略，可能包含股票回购计划

MAYNE PHARMA GROUP LTD上诉理由曝光，拟挑战法院对该公司2025财年息税折旧摊销前利润等事项的裁决

Mayne Pharma收到Cosette及其Bidco向新南威尔士州最高法院上诉庭提交的上诉通知

MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MYX.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":2.61,"timestamp":1771823520000,"preClose":2.65,"halted":0,"volume":1296768,"delay":0,"changeRate":-0.015094339622641523,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.187574,"marketStatus":"未开盘","change":-0.04,"latestTime":"02-23 16:12:00 AEDT","open":2.64,"high":2.66,"low":2.6,"amount":3388456,"amplitude":0.022642,"askPrice":2.64,"askSize":379,"bidPrice":2.59,"bidSize":7385,"shortable":3,"etf":0,"ttmEps":-1.187574,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1771887600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.65,"openAndCloseTimeList":[[1771801200000,1771822800000]],"volumeRatio":4.667326,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.28%","roe":"-21.85%","lyrEps":-1.185711,"volumeRatio":4.667326,"shares":81245827,"dividePrice":0,"high":2.66,"amplitude":0.022642,"preClose":2.65,"low":2.6,"week52Low":2.6,"pbRate":"0.57","psRate":"0.52","week52High":7.31,"institutionHeld":0,"latestPrice":2.61,"committee":0.90237,"eps":-1.187574,"divideRate":0,"volume":1296768,"delay":0,"ttmEps":-1.187574,"open":2.64,"prevYearClose":3.11,"prevWeekClose":2.65,"prevMonthClose":2.8,"prevQuarterClose":3.11,"fiveDayClose":2.71,"twentyDayClose":2.9,"sixtyDayClose":3.66,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null},{"date":"2024-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708902000000,"name":null,"time":"","dateTimestamp":1708866000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174229185","title":"Mayne制药集团——将继续推进产品组合规模化战略，可能包含股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1174229185","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174229185?lang=zh_cn&edition=fundamental","pubTime":"2026-02-23 06:38","pubTimestamp":1771799894,"startTime":"0","endTime":"0","summary":"Mayne制药集团宣布将持续推进其产品组合的规模化战略，并透露未来可能采取包括股票回购在内的多元化举措。这一战略方向旨在优化公司资本结构并提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1112976135","title":"MAYNE PHARMA GROUP LTD上诉理由曝光，拟挑战法院对该公司2025财年息税折旧摊销前利润等事项的裁决","url":"https://stock-news.laohu8.com/highlight/detail?id=1112976135","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112976135?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 12:57","pubTimestamp":1768453037,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD已提交上诉通知书，其中列明的上诉理由旨在对法院就该公司2025财年息税折旧摊销前利润及其他相关财务指标所作出的认定提出异议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1175178833","title":"Mayne Pharma收到Cosette及其Bidco向新南威尔士州最高法院上诉庭提交的上诉通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1175178833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175178833?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 12:56","pubTimestamp":1768453014,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd（ASX: MYX）近日宣布，已收到Cosette Pharmaceuticals及其关联收购实体（Bidco）向澳大利亚新南威尔士州最高法院上诉庭提交的上诉通知书。该上诉针对此前法院作出的相关裁决提出异议，标志着双方围绕商业纠纷的法律对抗进入新一轮司法程序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1124731935","title":"MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行","url":"https://stock-news.laohu8.com/highlight/detail?id=1124731935","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124731935?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 10:43","pubTimestamp":1765852990,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MYX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"医药生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.036783}]}}